Drug Patents owned by Xellia Pharms Aps

1. List of Vancomycin drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10188697 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US10039804 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US11000567 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US10849956 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

Drugs and Companies using VANCOMYCIN ingredient

Market Authorisation Date: 26 August, 2021

Treatment: Method of treating bacterial infections

Dosage: SOLUTION;INTRAVENOUS, ORAL

More Information on Dosage

2. List of Vancomycin Hydrochloride drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10188697 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US10039804 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US10849956 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

US11517609 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(12 years from now)

Drugs and Companies using VANCOMYCIN HYDROCHLORIDE ingredient

Market Authorisation Date: 15 February, 2019

Treatment: Method of treating bacterial infections

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic